12 October 2011 /Side effects and trials
Focus on medicines most frequently involved in serious adverse drug events can improve patient safety
A new study carried out by a working group associated with the Danish Medicines Agency's network "Prevention of Medication Errors" has shown that it is more or less the same groups of medicines that have been involved in the so-called adverse events from the 1970s and up until today. Based on the study, we have drawn up two lists of medicines that appear in high-risk situations – sorted by active substance and medicine group. The Danish Medicines Agency and the working group behind the study hope that these lists can become an important tool in the daily work with risks in the medication process in the health sector.
31 August 2009 /Side effects and trials
The Danish Medicines Agency has been informed through the Danish Patient Safety Database of six adverse incidents in the period from March 2007 to June 2009 involving the mix-up of medicines containing the active substances mirtazapine and mianserin.
10 September 2008 /Side effects and trials
07 November 2006 /Side effects and trials
Every year, mistakes and unintended incidents within the healthcare system, hereunder incorrect medication, cause patients and society great human and economic costs.